20043 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application; Pulmonary tract; Aromatherapy; Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy; for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
Dry Powder For Inhalation
#902Methods for delivering cromolyn
#903Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
#904Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
#905Matriptase inhibitors and uses thereof against orthomyxoviridae infections
#906Galactoside inhibitor of galectins
#907Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
#908Dry powder vancomycin compositions and associated methods
#909Compositions of glycopyrronium salt for inhalation
#910Pharmaceutical composition containing budesonide and formoterol
#911PHARMACEUTICAL COMPOSITIONS
#912Hydroxypropyl methyl cellulose hard capsules and process of manufacture
#913Preparation and method for use in the treatment of respiratory diseases
#914Treating auto-immune and auto-inflammatory diseases
#915Use of stearate in an inhalable formulation
#916Composition comprising at least two dry powders obtained by spray drying to increase the stability of the formulation
#917Pulmonary delivery of progestogen
#918COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND CORTICOSTEROIDS
#919Methods for treating respiratory diseases and formulations therefor
#920Dry powder formulations for inhalation
#921Micronized colistimethane sodium pharmaceutical compositions
#922Methods for reducing inter-patient variability of levodopa plasma concentrations
#923Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both β2 adrenergic receptor agonist and M3 muscarinic receptor antagonist activities
#924Drug combination
#925Micronized insulin and micronized insulin analogues prepared under acidic conditions, and methods of manufacturing the same under acidic conditions
#926Polypeptide
#927Drug combination of PDE3/PDE4 inhibitor and muscarinic receptor antagonist
#928Dry powder inhaler formulations comprising surface-modified particles with anti-adherent additives
#929PULMONARY DELIVERY OF A FLUOROQUINOLONE
#930DEAMORPHIZATION OF SPRAY-DRIED FORMULATIONS VIA SPRAY-BLENDING
#931Fluoroergoline analogs
#932Methods to treat inflammation of the lung
#933Biologic Scaffold For Prevention of Pulmonary Fibrosis
#934Pharmaceutical compositions comprising multi-component crystalline particles suitable for use in inhalation therapy
#935Inhalation particles comprising a combination of an anticholinergic, a corticosteroid and a beta-adrenergic
#936Multi-Component Crystalline Particles for Inhalation Therapy
#937Dry powder formulation comprising a phosphodiesterase inhibitor
#938Dosator apparatus for filling a capsule with dry powder
#939Ultra low density pulmonary powders
#940Dry powder formulations and methods for treating pulmonary diseases
#941NEW USE OF ACLIDINIUM
#942Composition
#943Capsules containing high doses of levodopa for pulmonary use
#944Combination of umeclidinium, fluticasone propionate and salmeterol xinafoate for use in the treatment of inflammatory or respiratory tract diseases
#945COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS
#9463,5-diamino-6-chloro-N-(n-(4-phenylbutyl)carbamimidoyl)pyrazine-2-carboxamide compounds
#947Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
#948PROCESS FOR MAKING AGGLOMERATES USING ACOUSTIC MIXING TECHNOLOGY
#949METHOD FOR TREATING HYPERGLYCEMIA WITH GLP-1
#950Method for preparing dry powder for inhalation formulation comprising salmeterol xinafoate, fluticasone propionate and tiotropium bromide
#951Nicotine Formulations and Methods of Making the Same
#952Inhalable vaccine compositions and methods
#953Galactoside inhibitor of galectin-3 and its use for treating pulmonary fibrosis
#954RAPAMYCIN FOR THE TREATMENT OF LYMPHANGIOLEIOMYOMATOSIS
#955COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING CHRONIC LUNG ALLOGRAFT DYSFUNCTION (CLAD) AND IDIOPATHIC PULMONARY FIBROSIS (IPF)
#956Dry powder formulations and methods for treating pulmonary diseases
#957Triazolyl derivatives as Syk inhibitors
#958METHODS AND COMPOSITIONS FOR ADMINISTRATION OF OXYBUTYNIN
#959Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
#960TIOTROPIUM PREPARATIONS
#961Methods and use of inducing apoptosis in cancer cells
#962METHOD AND COMPOSITION FOR TREATING HYPERGLYCEMIA
#963MONOVALENT METAL CATION DRY POWDERS FOR INHALATION
#964Acetamide stereoisomer
#965INHALATION COMPOSITIONS
#966Compositions of Glycopyrronium Salt for Inhalation
#967Methods for the Treatment of Lung Diseases with Mast Cell Stabilizers
#968Methods for the Treatment of Systemic Disorders Treatable with Mast Cell Stabilizers, including Mast Cell Related Disorders
#969Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery
#970Therapeutic for Treating Inflammatory Lung Disorders
#971COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND CORTICOSTEROIDS
#972Process for preparing carrier particles for dry powders for inhalation
#973DRY POWDER INHALERS COMPRISING A CARRIER OTHER THAN LACTOSE
#974Apparatus and method for simulating inhalation efforts
#975Dry powder formulations and methods for treating pulmonary diseases
#976Powder filling processes
#977COMPOSITIONS COMPRISING MUSCARINIC RECEPTOR ANTAGONIST AND GLUCOSE ANHYDROUS
#978COMPOSITIONS COMPRISING MUSCARINIC RECEPTOR ANTAGONIST AND SORBITOL
#979Inhalation compositions comprising glucose anhydrous
#980Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
#981Inhalation compositions comprising muscarinic receptor antagonist
#982Dry powder for inhalation formulation comprising salmeterol xinafoate, fluticasone propionate and tiotropium bromide, and method for preparing same
#983Methods and compositions for treating pain
#984PHARMACEUTICAL ANTI-INFECTIVE COMPOSITION FOR INHALATION
#985TREATMENT METHOD USING SOLID AMORPHOUS PARTICLES COMPRISING TIOTROPIUM BROMIDE AND A CO-SOLID
#986NOVEL DOSAGE FORM AND FORMULATION OF ABEDITEROL
#987Nanoclusters compositions and methods
#988System composed of inhaler and capsule
#989INHALABLE DRY POWDERS
#990Dry powder formulation
#991NOVEL DOSAGE AND FORMULATION
#992Crystalline 6-(2-((4-amino-3-(3-hydroxyphenyl)-1H-pyrazolo[3,4-D]pyrimidin-1-yl)methyl)-3-(2-chlorobenzyl)-4-0X0-3,4-dihydroquinazolin-5-yl)-N,N-bis(2-methoxyethyl)hex-5-ynamide
#993Uses of antagonists of hyaluronan signaling
#994Methods of treatment
#995NOVEL PHARMACEUTICAL FORMULATIONS
#996Fluoroergoline analogs
#997Dry powder inhaler
#998Pharmaceutical products and composition comprising specific anticholinergic agents, β-2 agonists and corticosteroids
#999Inhalable Epinephrine
#1000Pharmaceutical compositions for inhalation
#1001Organophosphates for treating afflictions of the skin
#1002Aggregate particles
#1003Pharmaceutical composition
#1004METHOD FOR TREATING HYPERGLYCEMIA
#1005Method of making particles for use in a pharmaceutical composition
#1006METHOD AND APPARATUS
#1007Pharmaceutical formulations for dry powder inhalers
#1008Dry powder inhaler and system for drug delivery
#1009AEROSOL TYROSINE KINASE INHIBITOR COMPOUNDS AND USES THEREOF
#1010Dry powder formulations of dNase I
#1011Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation
#1012DRY POWDER FORMULATION OF AZOLE DERIVATIVE FOR INHALATION
#1013Methods and compositions for treating mucosal tissue disorders
#1014NOVEL AEROSOL FORMULATIONS OF GRANISETRON AND USES THEREOF
#1015Inhalable liquid formulations of DNase I
#1016Antibiotic composition for inhalation and irrigation
#1017Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
#1018Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
#1019FORMULATION FOR PULMONARY ADMINISTRATION OF ANTIFUNGAL AGENTS, AND ASSOCIATED METHODS OF MANUFACTURE AND USE
#1020Pulmonary delivery of a fluoroquinolone
#1021Pharmaceutical composition for inhalation
#1022METHOD FOR TREATING BRONCHIAL DISEASES
#1023METHODS FOR TREATING AND DIAGNOSING RESPIRATORY TRACT INFECTIONS
#1024Dry powder formulations and methods of use
#1025Particle size reduction of an antimuscarinic compound
#1026Methods and compositions for treating pain
#1027Respirable agglomerates of porous carrier particles and micronized drug
#1028COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS
#1029Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
#1030Diketopiperazine microparticles with defined specific surface areas
#1031Respiratory disease treatment
#1032Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
#1033TREATING COUGH AND TUSSIVE ATTACKS
#1034Pharmaceutical compositions
#1035Propofol formulations with non-reactive container closures
#1036Capsules containing high doses of levodopa for pulmonary use
#1037Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast N-oxide
#1038Phospholipid-based powders for drug delivery
#1039Pulmonary delivery of aminoglycoside
#1040High capacity diketopiperazine microparticles and methods
#1041Inhalator and capsule for an inhalator
#1042FLUOROERGOLINE DERIVATIVES AND USES THEREOF
#1043Dry powder inhaler and methods of use
#1044Use of inhalable powder formulation comprising growth hormone for preventing or treating NMDA receptor hypofunction-related diseases
#1045Pharmaceutical compositions of dextran polymer derivatives
#1046Compounds
#1047Method for treating bronchial diseases
#1048Pharmaceutical composition
#1049Process for the preparation of fluticasone propionate form 1
#1050Solid compositions for pharmaceutical use
#1051Method for producing powders for inhalation
#1052Enzymes for inhibiting growth of biofilms and degrading same
#1053PROCESS FOR PREPARING SOLID AMORPHOUS PARTICLES COMPRISING TIOTROPIUM BROMIDE AND A CO-SOLID
#1054Novel Combination of Therapeutic Agents
#1055Pulmonary delivery for levodopa
#1056Use of ultrarapid acting insulin
#1057Zwitterionic immunomodulators for the treatment of asthma and allergy
#1058Matriptase inhibitors and uses thereof against orthomyxoviridae infections
#1059Dry powder inhaler and system for drug delivery
#1060Particulate materials
#1061Dry powder vancomycin compositions and associated methods
#1062Inhalable pharmaceutical compositions
#1063Diketopiperazine microparticles with defined specific surface areas
#1064Particles for use in a pharmaceutical composition
#1065Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
#1066Dry powder inhaler and system for drug delivery
#1067Pharmaceutical compositions of hydrophobic surface-modified active substance microparticles for inhalation
#1068Dry powder inhaler and system for drug delivery
#1069Dry powder formulations of particles that contain two or more active ingredients for treating obstructive or inflammatory airways diseases
#1070Airflow adaptor for a breath-actuated dry powder inhaler
#1071Low dose pharmaceutical powders for inhalation
#1072Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
#1073Dry powder inhaler and system for drug delivery
#1074COMPOSITIONS AND USES
#1075Methods and compositions for administration of oxybutynin
#1076Monovalent metal cation dry powders for inhalation
#1077Inhalable epinephrine
#1078Stable corticosteroid nanoparticulate formulations and methods for the making and use thereof
#1079Cationic dry powders
#1080Formulation and manufacture of pharmaceuticals by impregnation onto porous carriers
#1081Process for particle processing of active pharmaceutical ingredients
#1082Process for dry powder formulations
#1083Vaccines, methods of administering vaccines, methods and products for treating and/or delaying onset of dysplastic lesions, and wafers for oral administration
#1084DPI formulation containing sulfoalkyl ether cyclodextrin
#1085Method of preparing soy isoflavone nanoparticles by precipitation with compressed antisolvent (PCA) using a supercritical fluid
#1086Methods and compositions for administration of oxybutynin
#1087Dosage and formulation
#1088Respiratory formulations and compounds for use therein
#1089Pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger
#1090Methods and compositions for delivering peptides
#1091Humidified particles comprising a therapeutically active substance
#1092Dosage and formulation
#1093Delivery of Active Agents
#1094METHOD AND DEVICE FOR ADMINISTERING XINAFOATE SALT OF N4-(2,2-DIFLUORO-4H-BENZO [1,4]OXAZIN-3-ONE)-6-YL]-5-FLUORO-N2-[3- (METHYLAMINOCARBONYLMETHYLENEOXY) PHENYL]2,4-PYRIMIDINEDIAMINE
#1095Method of treating diabetes
#1096Degradation resistant HSP70 formulations and uses thereof
#1097Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery
#1098Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections
#1099Use of simple amino acids to form porous particles
#1100DRY POWDER INHALATION COMPOSITION
#1101Dry Powder Pharmaceutical Compositions, Its Preparation Process and Stable Aqueous Suspension Obtained from such Composition
#1102Compounds having muscarinic receptor antagonist and beta2 Adrenergic receptor agonist activity
#1103Aminotetralin compounds as mu opioid receptor antagonists
#11043-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
#1105COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS
#1106PHARMACEUTICAL POWDER COMPOSITION FOR INHALATION
#1107AEROSOLIZED NITRITE AND NITRIC OXIDE-DONATING COMPOUNDS AND USES THEREOF
#1108COMPOSITIONS CONTAINING SALMETEROL, FLUTICASONE AND CROMOGLICIC ACID
#1109Method of making composite particles for use in pharmaceutical compositions and composite particles and compositions thereof
#1110Dry powder formulation containing tiotropium for inhalation
#1111Dry powder formulations
#1112COMPOSITION
#1113Fluoroergoline analogs
#1114Powder compositions for inhalation
#1115Swellable particles for drug delivery
#1116CERIA FOR USE AS AN ANTIMICROBIAL BARRIER AND DISINFECTANT IN A WOUND DRESSING
#1117Diketopiperazine salts for drug delivery and related methods
#1118DEVICES AND PHARMACEUTICAL COMPOSITIONS FOR ENHANCING DOSING EFFICIENCY
#1119PHARMACEUTICAL COMPOSITIONS COMPRISING 17ALPHA-FURANYLESTERS OF 17BETA-CARBOTHIATE ANDROSTANES WITH A MUSCARINIC RECEPTOR ANTAGONIST
#1120ZWITTERIONIC IMMUNOMODULATORS FOR THE TEATMENT OF ASTHMA AND ALLERGY
#1121Barrier composition
#1122COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS
#1123COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS
#1124COMBINATIONS OF A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2 ADRENORECEPTOR AGONIST
#1125METHODS AND USE OF INDUCING APOPTOSIS IN CANCER CELLS
#1126FORMULATIONS FOR USE IN INHALER DEVICES
#1127COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND CORTICOSTEROIDS
#1128Steroid-sparing effects of beta-adrenergic inverse agonists and uses thereof
#1129Methods and compositions for maintaining active agents in intra-articular spaces
#1130USE OF INHALABLE POWDER FORMULATION COMPRISING GROWTH HORMONE FOR PREVENTING OR TREATING NMDA RECEPTOR HYPOFUNCTION-RELATED DISEASES
#1131NIOSOMES, FREEZE-DRIED POWDER THEREOF AND THEIR USE IN TREATMENT
#1132Pharmaceutical compositions of active agents and cationic dextran polymer derivatives
#1133Respiratory disease treatment
#1134EMERGENCY CONTRACEPTIVE
#1135COMBINATION OF MEDICAMENTS FOR THE TREATMENT OF RESPIRATORY DISEASES
#1136USE OF A2B ADENOSINE RECEPTOR ANTAGONISTS FOR TREATING HEART FAILURE AND ARRHYTHMIA IN POST-MYOCARDIAL INFARCTION PATIENTS
#1137DRONABINOL TREATMENT FOR MIGRAINES
#1138Val (8) GLP-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome
#1139Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
#1140Stabilized pharmaceutical product
#1141Apparatus and method for simulating inhalation efforts
#1142Method Of Therapeutic Administration of DHE To Enable Rapid Relief Of Migraine While Minimizing Side Effect Profile
#1143DRY POWDER AEROSOLS OF NANOPARTICULATE DRUGS
#1144INHALER FOR THE ADMINISTRATION OF AN ANTICHOLINERGIC
#1145Methods and systems for dosing and coating inhalation powders onto carrier particles
#1146Pretreatment of Post Exposure Treatment for Exposure to a Toxic Substance by Pulmonary Delivery (Inhaler) of a Bioscavenger
#1147PHARMACEUTICAL COMPOSITIONS BASED ON ANTICHOLINERGICS AND CORTICOSTEROIDS
#1148Soft anticholinergic esters
#1149Diketopiperazine microparticles with defined specific surface areas
#1150DPI formulation containing sulfoalkyl ether cyclodextrin
#1151METHOD FOR THE PRODUCTION OF COMMERCIAL NANOPARTICLE AND MICRO PARTICLE POWDERS
#1152Anhydrate of tiotropium bromide
#1153Methods of treatment of endobronchial infections
#1154Steroid Solavates
#1155Technology for the Preparation of Microparticles
#1156Soft anticholinergic zwitterions
#1157DRY POWDER COMPOSITION COMPRISING CO-JET MILLED PARTICLES FOR PULMONARY INHALATION
#1158Dry Powder Inhaler Formulations
#1159USE OF MOMETASONE FUROATE FOR TREATING AIRWAY PASSAGE AND LUNG DISEASE
#1160UNIT DOSE DRY POWDER INHALER
#1161Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
#1162Theobromine for the treatment of cough
#1163Compositions Comprising Amphotericin B
#1164Method for producing salt dust and salt dust generator
#1165THE USE OF AMLEXANOX IN THE THERAPY OF NEUTROPHIL-DRIVEN DISEASES
#1166Quinuclidine derivatives and medicinal compositions containing the same
#1167Use of ultrarapid acting insulin
#1168Method of treating diabetes type 2 by administering ultrarapid acting insulin
#1169FORMULATIONS FOR USE IN INHALER DEVICES
#1170Low dose pharmaceutical powders for inhalation
#1171Dry powder drug delivery formulations, methods of use, and devices therefore
#1172Dry powder formulations
#1173Particles for Inhalation Having Sustained Release Properties
#1174AGGLOMERATE FORMULATIONS INCLUDING ACTIVE PHARMACEUTICAL AGENTS WITH TARGETED PARTICLE SIZES
#1175Method for treating hyperglycemia with GLP-1
#1176Highly efficient delivery of a large therapeutic mass aerosol
#1177INHALABLE AZTREONAM FOR TREATMENT AND PREVENTION OF PULMONARY BACTERIAL INFECTIONS
#1178Synthesis of small particles
#1179Aminotetralin compounds as mu opioid receptor antagonists
#11803-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
#1181COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS
#1182Pulmonary Delivery in Treating Disorders of the Central Nervous System
#1183CALCIUM CITRATE AND CALCIUM LACTATE FORMULATIONS FOR ALTERATION OF BIOPHYSICAL PROPERTIES OF MUCOSAL LINING
#1184Pharmaceutical anti-infective composition for inhalation
#1185USE OF MAGNESIUM STEARATE IN DRY POWDER FORMULATIONS FOR INHALATION
#1186USE OF R-BAMBUTEROL AS INHALED MEDICAMENT AND COMBINATION THERAPIES FOR TREATMENT OF RESPIRATORY DISORDERS
#1187METHODS AND COMPOSITIONS FOR DISEASE TREATMENT USING INHALATION
#1188Targeted Lung Delivery of Citrulline and/or Another Nitric Oxide Precursor and a Method for Treatment of Pulmonary Deficiency of Nitric Oxide in Cystic Fibrosis and Other Pulmonary Diseases
#1189Combination of anticholinergics, β2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases
#1190Method and composition for treating migraines
#1191COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND CORTICOSTERIODS
#1192Pharmaceutical composition for inhalation
#1193ANTI-INFLUENZA FORMULATIONS AND METHODS
#1194METHOD OF PREPARING DRY POWDER INHALATION COMPOSITIONS
#1195COMPOSITIONS OF GLYCOPYRRONIUM SALT FOR INHALATION
#1196Antimicrobial Cyclocarbonyl Heterocyclic Compounds For Treatment Of Bacterial Infections
#1197DRY POWDER FORMULATIONS AND METHODS FOR TREATING PULMONARY DISEASES
#1198Pharmaceutical preparation to be administered into respiratory organs for treating or preventing inflammatory respiratory diseases, and method for treating or preventing such diseases
#1199COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS
#1200METHODS FOR TREATING AND PREVENTING PNEUMONIA AND VENTILATOR-ASSOCIATED TRACHEOBRONCHITIS